Robert Baffi - BioMarin Pharmaceutical Executive VP of Technical Operations

BMRN -- USA Stock  

USD 97.69  0.18  0.00%

Dr. Robert A. Baffi, Ph.D., serves as an Executive Vice President Technical Operations of Biomarin Pharmaceutical Inc. He joined BioMarin in May 2000 and currently serves as our Executive Vice President of Technical Operations, responsible for overseeing our manufacturing, process development, quality, and analytical chemistry departments. From 2000 to December 2009, Dr. Baffi served as our Senior Vice President of Technical Operations. From 1986 to 2000, Dr. Baffi served in a number of increasingly responsible positions at Genentech, Inc., primarily in the functional area of quality control. Prior to Genentech, Dr. Baffi worked for Cooper BioMedical as a Research Scientist and at Becton Dickinson Research Center as a PostDoctoral Fellow. Dr. Baffi has contributed to more than 20 regulatory submissions for product approval in the United States and Europe and to more than 50 regulatory submissions for investigational new drug testing. He currently serves on the board for the National Institute for Bioprocessing Research Training
Age: 62  EVP Since 2009  MBA    
Baffi received a Ph.D., M. Phil and a B.S. in biochemistry from the City University of New York and an M.B.A. from Regis University.

Robert Baffi Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (1.89) % which means that it has lost $1.89 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (4.36) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 1.2B in liabilities with Debt to Equity (D/E) ratio of 41.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BioMarin Pharmaceutical has Current Ratio of 2.81 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

BioMarin Pharmaceutical, Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. The company was founded in 1996 and is headquartered in San Rafael, California. BioMarin Pharmaceutical operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 2581 people.BioMarin Pharmaceutical (BMRN) is traded on BATS Exchange in USA. It is located in 770 Lindaro Street and employs 2,581 people. BioMarin Pharmaceutical is listed under Pharmaceutical Products category by Fama And French industry classification.

BioMarin Pharmaceutical Leadership Team

Elaine Heron, Independent Director
Dennis Slamon, Director
Henry Fuchs, Executive Vice President and Chief Medical Officer
Robert Hombach, Independent Director
Brian Mueller, Chief Accounting Officer, Group VP and Controller
Bryan Lawlis, Independent Director
JeanJacques Bienaime, Chairman of the Board, CEO
Jeff Ajer, Executive Vice President Chief Commercial Officer
Richard Meier, Independent Director
Willard Dere, Director
Daniel Spiegelman, CFO, Executive Vice President
Kathryn Falberg, Director
Eric Davis, Sr. VP, General Counsel and Secretary
Pierre Lapalme, Independent Chairman of the Board
Robert Baffi, Executive VP of Technical Operations
Alan Lewis, Independent Director
Richard Ranieri, Senior Vice President - Human Resources and Corporate Affairs
David Pyott, Independent Director
Michael Grey, Independent Director

Stock Performance Indicators

Did you try this?

Run Portfolio Anywhere Now


Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Portfolio Anywhere

BioMarin Pharmaceutical Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for BioMarin Pharmaceutical and China Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try CEO Directory module to screen ceos from public companies around the world.